Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

NCT00795093 · clinicaltrials.gov ↗

COMPLETED

Status

552

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastroesophageal Reflux Disease (GERD)

Sponsor

AstraZeneca

Collaborators

[object Object]